Citation
Zhang, Xuehong, et al. "Risk of Colon Cancer and Coffee, Tea, and Sugar-sweetened Soft Drink Intake: Pooled Analysis of Prospective Cohort Studies." Journal of the National Cancer Institute, vol. 102, no. 11, 2010, pp. 771-83.
Zhang X, Albanes D, Beeson WL, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst. 2010;102(11):771-83.
Zhang, X., Albanes, D., Beeson, W. L., van den Brandt, P. A., Buring, J. E., Flood, A., Freudenheim, J. L., Giovannucci, E. L., Goldbohm, R. A., Jaceldo-Siegl, K., Jacobs, E. J., Krogh, V., Larsson, S. C., Marshall, J. R., McCullough, M. L., Miller, A. B., Robien, K., Rohan, T. E., Schatzkin, A., ... Smith-Warner, S. A. (2010). Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. Journal of the National Cancer Institute, 102(11), 771-83. https://doi.org/10.1093/jnci/djq107
Zhang X, et al. Risk of Colon Cancer and Coffee, Tea, and Sugar-sweetened Soft Drink Intake: Pooled Analysis of Prospective Cohort Studies. J Natl Cancer Inst. 2010 Jun 2;102(11):771-83. PubMed PMID: 20453203.
TY - JOUR
T1 - Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies.
AU - Zhang,Xuehong,
AU - Albanes,Demetrius,
AU - Beeson,W Lawrence,
AU - van den Brandt,Piet A,
AU - Buring,Julie E,
AU - Flood,Andrew,
AU - Freudenheim,Jo L,
AU - Giovannucci,Edward L,
AU - Goldbohm,R Alexandra,
AU - Jaceldo-Siegl,Karen,
AU - Jacobs,Eric J,
AU - Krogh,Vittorio,
AU - Larsson,Susanna C,
AU - Marshall,James R,
AU - McCullough,Marjorie L,
AU - Miller,Anthony B,
AU - Robien,Kim,
AU - Rohan,Thomas E,
AU - Schatzkin,Arthur,
AU - Sieri,Sabina,
AU - Spiegelman,Donna,
AU - Virtamo,Jarmo,
AU - Wolk,Alicja,
AU - Willett,Walter C,
AU - Zhang,Shumin M,
AU - Smith-Warner,Stephanie A,
Y1 - 2010/05/07/
PY - 2010/5/11/entrez
PY - 2010/5/11/pubmed
PY - 2010/6/15/medline
SP - 771
EP - 83
JF - Journal of the National Cancer Institute
JO - J Natl Cancer Inst
VL - 102
IS - 11
N2 - BACKGROUND: The relationships between coffee, tea, and sugar-sweetened carbonated soft drink consumption and colon cancer risk remain unresolved. METHODS: We investigated prospectively the association between coffee, tea, and sugar-sweetened carbonated soft drink consumption and colon cancer risk in a pooled analysis of primary data from 13 cohort studies. Among 731 441 participants followed for up to 6-20 years, 5604 incident colon cancer case patients were identified. Study-specific relative risks (RRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models and then pooled using a random-effects model. All statistical tests were two-sided. RESULTS: Compared with nonconsumers, the pooled multivariable relative risks were 1.07 (95% CI = 0.89 to 1.30, P(trend) = .68) for coffee consumption greater than 1400 g/d (about six 8-oz cups) and 1.28 (95% CI = 1.02 to 1.61, P(trend) = .01) for tea consumption greater than 900 g/d (about four 8-oz cups). For sugar-sweetened carbonated soft drink consumption, the pooled multivariable relative risk comparing consumption greater than 550 g/d (about 18 oz) to nonconsumers was 0.94 (95% CI = 0.66 to 1.32, P(trend) = .91). No statistically significant between-studies heterogeneity was observed for the highest category of each beverage consumed (P > .20). The observed associations did not differ by sex, smoking status, alcohol consumption, body mass index, physical activity, or tumor site (P > .05). CONCLUSIONS: Drinking coffee or sugar-sweetened carbonated soft drinks was not associated with colon cancer risk. However, a modest positive association with higher tea consumption is possible and requires further study.
SN - 1460-2105
UR - https://www.unboundmedicine.com/medline/citation/20453203/Risk_of_colon_cancer_and_coffee_tea_and_sugar_sweetened_soft_drink_intake:_pooled_analysis_of_prospective_cohort_studies_
L2 - https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djq107
DB - PRIME
DP - Unbound Medicine
ER -